InChI=1S/C46H58N4O9/c1- 8- 42(54) 23- 28- 24- 45(40(52) 57- 6,36- 30(15- 19- 49(25- 28) 26- 42) 29- 13- 10- 11- 14- 33(29) 47- 36) 32- 21- 31- 34(22- 35(32) 56- 5) 48(4) 38- 44(31) 17- 20- 50- 18- 12- 16- 43(9- 2,37(44) 50) 39(59- 27(3) 51) 46(38,55) 41(53) 58- 7/h10- 14,16,21- 22,28,37- 39,47,54- 55H,8- 9,15,17- 20,23- 26H2,1- 7H3/t28- ,37+,38- ,39- ,42+,43- ,44- ,45+,46+/m1/s1 |
JXLYSJRDGCGARV-XQKSVPLYSA-N |
[H] [C@@] 12N3CC[C@@] 11c4cc(c(OC) cc4N(C) [C@@] 1([H] ) [C@] (O) ([C@H] (OC(C) =O) [C@] 2(CC) C=CC3) C(=O) OC) [C@] 1(C[C@@H] 2CN(CCc3c1[nH] c1ccccc31) C[C@] (O) (CC) C2) C(=O) OC |
|
Catharanthus roseus
(NCBI:txid4058)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
microtubule-destabilising agent
Any substance that interacts with tubulin to inhibit polymerisation of microtubules.
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
immunosuppressive agent
An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
immunosuppressive agent
An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
|
|
View more via ChEBI Ontology
vinblastina
|
WHO MedNet
|
vinblastine
|
WHO MedNet
|
vinblastine
|
WHO MedNet
|
vinblastinum
|
WHO MedNet
|
(+)-vinblastine
|
ChEBI
|
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
|
PDBeChem
|
VLB
|
ChemIDplus
|
2823
|
DrugCentral
|
C00001781
|
KNApSAcK
|
C07201
|
KEGG COMPOUND
|
D08675
|
KEGG DRUG
|
DB00570
|
DrugBank
|
HMDB0014710
|
HMDB
|
Vinblastine
|
Wikipedia
|
VLB
|
PDBeChem
|
View more database links |
4779207
|
Beilstein Registry Number
|
Beilstein
|
865-21-4
|
CAS Registry Number
|
KEGG COMPOUND
|
865-21-4
|
CAS Registry Number
|
ChemIDplus
|
11878966
|
PubMed citation
|
Europe PMC
|
15917812
|
PubMed citation
|
Europe PMC
|
20394103
|
PubMed citation
|
Europe PMC
|
22868758
|
PubMed citation
|
Europe PMC
|
25586069
|
PubMed citation
|
Europe PMC
|
26660762
|
PubMed citation
|
Europe PMC
|
27518442
|
PubMed citation
|
Europe PMC
|
35404502
|
PubMed citation
|
Europe PMC
|
|